騰訊(00700.HK)旗下一款Switch遊戲獲批國產遊戲版號
國家新聞出版廣電總局官網顯示,6月首批共55款國產遊戲版號獲批,當中騰訊(00700.HK)上榜,由騰訊NEXT Studios開發的Switch遊戲《不思議的皇冠》獲批遊戲版號。
其餘獲批遊戲包括嗶哩嗶哩的《空匣人型》、三七互娛的《上古之神》(頁游)、多益網路的《白夜棋跡對決》、盛趣遊戲的《慶餘年》、西山居的《沉沒世紀》、游族網路的《新盜墓筆記》、創夢天地(01119.HK)的《雛蜂:深淵天使》等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.